Your browser doesn't support javascript.
Working Hard or Hardly Working? Regulatory Bottlenecks in Developing a COVID-19 Vaccine.
Pregelj, Lisette; Hine, Damian C; Oyola-Lozada, Maria G; Munro, Trent P.
  • Pregelj L; School of Chemistry and Molecular Biosciences and Australian Institute for Business and Economics, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Hine DC; Kemmy Business School, University of Limerick, Limerick, V94 T9PX, Ireland.
  • Oyola-Lozada MG; School of Chemistry and Molecular Biosciences and Faculty of Business, Economics and Law, The University of Queensland, St Lucia, Queensland 4072, Australia.
  • Munro TP; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, Queensland 4072, Australia. Electronic address: t.munro@uq.edu.au.
Trends Biotechnol ; 38(9): 943-947, 2020 09.
Article in English | MEDLINE | ID: covidwho-597298
ABSTRACT
Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5 years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines.
Subject(s)
Coronavirus Infections/prevention & control; Drug Approval/organization & administration; Hemorrhagic Fever, Ebola/prevention & control; Influenza, Human/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/biosynthesis; Betacoronavirus/drug effects; Betacoronavirus/immunology; Betacoronavirus/pathogenicity; COVID-19; COVID-19 Vaccines; Coronavirus Infections/epidemiology; Coronavirus Infections/immunology; Coronavirus Infections/virology; Ebola Vaccines/administration & dosage; Ebola Vaccines/biosynthesis; Ebolavirus/drug effects; Ebolavirus/immunology; Ebolavirus/pathogenicity; Europe/epidemiology; Global Health/trends; Government Regulation; Hemorrhagic Fever, Ebola/epidemiology; Hemorrhagic Fever, Ebola/immunology; Hemorrhagic Fever, Ebola/virology; Humans; Influenza A Virus, H1N1 Subtype/genetics; Influenza A Virus, H1N1 Subtype/immunology; Influenza Vaccines/administration & dosage; Influenza Vaccines/biosynthesis; Influenza, Human/epidemiology; Influenza, Human/immunology; Influenza, Human/virology; Middle East Respiratory Syndrome Coronavirus/drug effects; Middle East Respiratory Syndrome Coronavirus/immunology; Middle East Respiratory Syndrome Coronavirus/pathogenicity; Pneumonia, Viral/epidemiology; Pneumonia, Viral/immunology; Pneumonia, Viral/virology; Severe acute respiratory syndrome-related coronavirus/drug effects; Severe acute respiratory syndrome-related coronavirus/immunology; Severe acute respiratory syndrome-related coronavirus/pathogenicity; SARS-CoV-2; Severe Acute Respiratory Syndrome/epidemiology; Severe Acute Respiratory Syndrome/immunology; Severe Acute Respiratory Syndrome/prevention & control; Severe Acute Respiratory Syndrome/virology; United States/epidemiology; Viral Vaccines/administration & dosage; Zika Virus/drug effects; Zika Virus/immunology; Zika Virus/pathogenicity; Zika Virus Infection/epidemiology; Zika Virus Infection/immunology; Zika Virus Infection/prevention & control; Zika Virus Infection/virology
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Drug Approval / Coronavirus Infections / Hemorrhagic Fever, Ebola / Influenza, Human / Pandemics Type of study: Observational study / Prognostic study Topics: Vaccines Country/Region as subject: North America / Europa Language: English Journal: Trends Biotechnol Year: 2020 Document Type: Article Affiliation country: J.tibtech.2020.06.004

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Drug Approval / Coronavirus Infections / Hemorrhagic Fever, Ebola / Influenza, Human / Pandemics Type of study: Observational study / Prognostic study Topics: Vaccines Country/Region as subject: North America / Europa Language: English Journal: Trends Biotechnol Year: 2020 Document Type: Article Affiliation country: J.tibtech.2020.06.004